OSA Clinical Trial
Official title:
Impact of Intermittent Hypoxia on Neutrophil Extracellular Traps
This prospective observational study will enroll 60 moderate-to-severe OSA patients (AHI≧15/hour, 30 obese [BMI>=27] & 30 non-obese [BMI<27]) and 40 age-, gender-, BMI-matched controls without OSA. Venous blood 10 ml will be collected to isolate neutrophils, which are later tested for their ability to produce neutrophil extracellular traps (NETs) under the effect of PMA (phorbol 12-myristate 13-acetate). The test will be repeated if OSA patients receive CPAP therapy (continous positive airway pressure therapy).
Obstructive sleep apnea (OSA) is a common disease, affecting around one billion people worldwide. This disorder is characterized by repetitive upper airway collapse during sleep, thereby leading to intermittent hypoxia (IH). The severity of OSA is gauged by AHI(apnea-hypopnea index), which can be determined by a sleep test, polysomnography. Literature revealed OSA confers a higher risk for incident pneumonia and sepsis-related adverse outcomes, suggestive of defective immunity in those patients. CPAP therapy (continous positive airway pressure therapy) is the mainstay treatment for OSA. This research is aimed to investigate the impact of IH on the ability of neutrophils to produce neutrophil extracellular traps (NETs). We will enroll 60 moderate-to-severe OSA patients (AHI≧15/hour, 30 obese [BMI>=27] & 30 non-obese [BMI<27]) and 40 age-, gender-, BMI-matched controls without OSA. Venous blood 10 ml will be collected to isolate neutrophils, which are later tested for their ability to produce NETs under the effect of PMA (phorbol 12-myristate 13-acetate). ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05404438 -
Mouth Breathing Habits Improvement Intervention
|
N/A | |
| Recruiting |
NCT05960175 -
Impact of Patient Involvement in Alerts Management of Telemonitoring CPAP
|
N/A | |
| Recruiting |
NCT05813275 -
Parallel-Arm Study to Compare AD109 to Placebo With Patients With OSA (SynAIRgy Study)
|
Phase 3 | |
| Completed |
NCT05075668 -
Efficacy of HFNC as an Alternative to CPAP Therapy in Surgical Patients With Suspected Moderate to Severe OSA
|
N/A | |
| Completed |
NCT05881512 -
Early Feasibility Study of Transcutaneous Upper Airway Stimulation in Obstructive Sleep Apnea
|
N/A | |
| Completed |
NCT03336515 -
Validity of a Vibrating Postural Device for the Treatment of Positional Obstructive Sleep Apnea (Postural)
|
N/A | |
| Not yet recruiting |
NCT05944965 -
Pharyngeal Muscle Control Mechanisms of Atomoxetine-plus-oxybutynin in Obstructive Sleep Apnea
|
Phase 1/Phase 2 | |
| Completed |
NCT02387476 -
Non-Inferiority Study of the FRESCA Mask Versus Existing CPAP Mask for Treatment of Obstructive Sleep Apnea
|
N/A | |
| Not yet recruiting |
NCT06058052 -
Prevalence of OSA in Patients of ILD
|
||
| Recruiting |
NCT03721445 -
Could HRV be a Valuable Predictor for CPAP Adherence?
|
||
| Completed |
NCT03172130 -
Sham CPAP vs. Straight CPAP for Chronic Cough
|
N/A | |
| Recruiting |
NCT06320795 -
Prospective Study for the Clinical Validation of the Soundi Wearable Medical Device
|
N/A | |
| Completed |
NCT01717339 -
Sleep Apnea and Vascular Function
|
N/A | |
| Completed |
NCT00772044 -
Randomized Study of Provent Versus Sham Device to Treat Obstructive Sleep Apnea
|
Phase 4 | |
| Recruiting |
NCT06400615 -
Study That Tests AD109 in Patients Taking GLP-1 Drugs
|
Phase 2 | |
| Completed |
NCT02438137 -
Dimethyl Fumarate for Obstructive Sleep Apnea
|
N/A | |
| Completed |
NCT01672606 -
Effect of Rocuronium on the Acute Hypoxic Ventilatory Response in Patients With Obstructive Sleep Apnea
|
N/A | |
| Not yet recruiting |
NCT06110962 -
Detecting Heart Rate, Respiration, and Sleep With the Sleeptracker-AI Under-mattress Monitor
|
||
| Completed |
NCT05060133 -
Changes of the Upper Airway Volume After Orthognathic Surgery
|
||
| Completed |
NCT03196583 -
Efficacy of a Novel MAD in OSA
|
N/A |